Merck & Co., Inc. (NYSE:MRK) is included among the 16 Best Dividend Stocks with Rising Payouts. On February 13, Deutsche Bank ...
Zacks Investment Research on MSN
Merck vs. Bristol Myers: Which pharma stock is a better pick in 2026?
Merck & Co. MRK and Bristol Myers Squibb BMY are major global drugmakers with expansive, diversified portfolios. Merck stands ...
Merck says 2026 earnings will take a hit due to its pending takeover of Cidara Therapeutics.
Merck (MRK) pharma stock has been on a climb for some time now but has recently stalled near a familiar breakdown zone ...
Merck demonstrates excellence across the board through its resilient revenue mix, expanding profitability, and stellar capital allocation. MRK's innovation, highlighted by Keytruda's dominance and ...
Merck & Co. Inc. stock reached a 52-week high, closing at $122.69. This milestone highlights a significant upward trend for the pharmaceutical giant, marking a notable recovery and growth over the ...
Merck & Co. is no longer a deep-value patent cliff trade but a fairly valued defensive compounder. Read why I have downgraded ...
We recently published Wall Street Analysts Like These 10 Stocks. Merck & Co., Inc. (NYSE:MRK) is one of the stocks analysts were recently talking about. Bill Nygren, Oakmark Funds partner and CIO, ...
We recently published 8 Stocks on Jim Cramer’s Radar. Merck & Co., Inc. (NYSE:MRK) is one of the stocks on Jim Cramer’s radars. Pharma giant Merck & Co., Inc. (NYSE:MRK)’s shares are up by 1.9% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results